Express Pharma

JUNE 12, 2024

In 2023, while the deal volume declined, the deal value grew (1), due to strategic megadeals in the pharma sector. billion in 2023, there is compelling investor interest in medtech and biotech companies. India’s pharmaceutical sector is on a growth trajectory. Taking a cue from Pfizer’s acquisition of cancer drugmaker Seagen for $45.7

Generic Medicine 101

Generic Medicine Vaccines Diabetes Immunity 101

Express Pharma

JUNE 21, 2024

In 2023, while the deal volume declined, the deal value grew1, due to strategic megadeals in the pharma sector. billion in 2023, there is compelling investor interest in medtech and biotech companies. India’s pharmaceutical sector is on a growth trajectory. Taking a cue from Pfizer’s acquisition of cancer drugmaker Seagen for $45.7

Generic Medicine 88

Generic Medicine Vaccines Diabetes Immunity 88

Express Pharma

JULY 3, 2023

By empowering process development scientists to generate process quality attribute (PQA) data themselves, we enable them to make decisions about which molecules to advance into pre-clinical development more rapidly. resin consumption), and effectively monitor and manage product quality. How poised are you to leverage them?

Biosimilars 81

Biosimilars Drug Development Generic Medicine Diabetes 81

Express Pharma

SEPTEMBER 11, 2023

So, the government shouldered the responsibility of manufacturing all basic essential antibiotics and medicines. Karnataka Antibiotics, and Bengal Immunity, etc. ” After shifting the focus to a “market-based economy,” the government’s medicine policies became more liberal, generous, and pro-industry.

Generic Medicine 69

Generic Medicine Diabetes Immunity Immunization 69